1. Kim YJ, Tian C, Kim J, Shin B, Choo OS, Kim YS et al. Autophagic flux, a possible mechanism for delayed gentamicin-induced ototoxicity. Scientific Reports 2017; 7: 41356.
2. Xie J, Talaska AE, Schacht J. New developments in aminoglycoside therapy and ototoxicity. Hear Res 2011; 281: 28-37.
3. Dror AA, Avraham KB. Hearing impairment: a panoply of genes and functions. Neuron 2010; 68: 293-308.
4. Menezes da Silveira CCS, Luz DA, da Silva CCS, Prediger RDS, Martins MD, Martins MAT et al. Propolis: A useful agent on psychiatric and neurological disorders? A focus on CAPE and pinocembrin components. Med Res Rev 2021; 41: 1195-1215.
5. Agrı I, Erdal Agrı A, Ozdemir D, Ozgur A. CAPE and Tympanosclerosis. In: Watson RR, Preedy VR, Zibadi S, Eds. Polyphenols: Mechanisms of Action in Human Health and Disease. 2nd ed. Academic Press Elsevier; 2018. p. 421–430.
6. Sforcin JM, Bankova V. Propolis: is there a potential for the development of new drugs? J Ethnopharmacol 2011; 133: 253-260.
7. Toreti VC, Sato HH, Pastore GM, Park YK. Recent progress of propolis for its biological and chemical compositions and its botanical origin. Evid Based Complement Alternat Med 2013; 2013: 697390.
8. Ozen S, Akyol O, Iraz M, Sogut S, Ozugurlu F, Ozyurt H et al. Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats. J Appl Toxicol 2004; 24: 27-35.
9. Lee KJ, Choi JH, Khanal T, Hwang YP, Chung YC, Jeong HG. Protective effect of caffeic acid phenethyl ester against carbon tetrachloride-induced hepatotoxicity in mice. Toxicology 2008; 248: 18-24.
10. Fadillioglu E, Oztas E, Erdogan H, Yagmurca M, Sogut S, Ucar M et al. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats. J Appl Toxicol 2004; 24: 47-52.
11. Yildiz OG, Soyuer S, Saraymen R, Eroglu C. Protective effects of caffeic acid phenethyl ester on radiation induced lung injury in rats. Clin Invest Med 2008; 31: E242-247.
12. Uzar E, Koyuncuoglu HR, Uz E, Yilmaz HR, Kutluhan S, Kilbas S et al. The activities of anti-oxidant enzymes and the level of malondialdehyde in cerebellum of rats subjected to methotrexate: protective effect of caffeic acid phenethyl ester. Mol Cell Biochem 2006 ;291: 63-68.
13. Balaha M, De Filippis B, Cataldi A, di Giacomo V. CAPE and Neuroprotection: A Review. Biomolecules 2021; 11: 176.
14. Atik OS, Erdogan D, Seymen CM, Bozkurt HH, Take Kaplanoglu G: Is there crosstalk between subchondral bone, cartilage, and meniscus in the pathogenesis of osteoarthritis? Joint Diseases and Related Surgery 2016; 27: 62-67.
15. Schacht J. Aminoglycoside ototoxicity: prevention in sight? Otolaryngology Head and Neck Surgery 1998; 118: 674-677.
16. Fetoni AR, Eramo SL, Rolesi R, Troiani D, Paludetti G. Anti-oxidant treatment with coenzyme Q-ter in prevention of gentamycin ototoxicity in an animal model. Acta Otorhinolaryngol Ital 2012; 32: 103-110.
17. Somdaş MA, Korkmaz F, Gürgen SG, Sagit M, Akçadağ A. N-acetylcysteine Prevents Gentamicin Ototoxicity in a Rat Model. The Journal of International Advanced Otology 2015; 11: 12-18.
18. Fu X, Wan P, Li P, Wang J, Guo S, Zhang Y et al. Mechanism and Prevention of Ototoxicity Induced by Aminoglycosides. Front Cell Neurosci 2021; 15: 692762.
19. Nomura K, Naruse K, Watanabe K, Sokabe M. Aminoglycoside blockade of Ca2(+)-activated K+ channel from rat brain synaptosomal membranes incorporated into planar bilayers. The Journal of Membrane Biology 1990; 115: 241-251.
20. Marcotti W, Van Netten SM, Kros CJ. The aminoglycoside antibiotic dihydrostreptomycin rapidly enters mouse outer hair cells through the mechano-electrical transducer channels. The Journal of Physiology 2005; 567: 505-521.
21. Pavlidis P, Maurer J, Apostolidou E, Kekes G, Kouvelas D. Memantine’s action against aminoglycoside-induced ototoxicity. Eur Arch Otorhinolaryngol 2014; 271: 1491-1496.
22. Mostafa BE, Tawfik S, Hefnawi NG, Hassan MA, Ismail FA. The role of deferoxamine in the prevention of gentamicin ototoxicity: a histological and audiological study in guinea pigs. Acta Otolaryngology 2007 ;127: 234-239.
23. Campbell KC, Martin SM, Meech RP, Hargrove TL, Verhulst SJ, Fox DJ. D-methionine (D-met) significantly reduces kanamycin-induced ototoxicity in pigmented guinea pigs. Int J Audiol 2016; 55: 273-278.
24. Park SK, Choi D, Russell P, John EO, Jung TT. Protective effect of corticosteroid against the cytotoxicity of aminoglycoside otic drops on isolated cochlear outer hair cells. Laryngoscope 2004; 114: 768-771.
25. Dogan M, Polat H, Yasar M, Bayram A, Karatas D, Hira I et al. Protective role of misoprostol in prevention of gentamicin ototoxicity. International Journal of Pediatric Otorhinolaryngology 2017; 96: 140-144.
26. Akyol S, Isik B, Altuntas A, Erden G, Cakmak O, Kurşunlu SF et al. Future opportunities in preventing ototoxicity: Caffeic acid phenethyl ester may be a candidate (Review). Mol Med Rep 2015; 12: 3231-3235.
27. Park MK, Im GJ, Chang J, Chae SW, Yoo J, Han WG et al. Protective effects of caffeic acid phenethyl ester (CAPE) against neomycin-induced hair cell damage in zebrafish. International journal of pediatric otorhinolaryngology 2014; 78: 1311–1315.
28. Kizilay A, Kalcioglu MT, Ozerol E, Iraz M, Gulec M, Akyol O et al. Caffeic acid phenethyl ester ameliorated ototoxicity induced by cisplatin in rats. Journal of Chemotherapy 2004; 16: 381-387.
29. Bakir S, Ozbay M, Gun R, Yorgancilar E, Kinis V, Keles A et al. The protective role of caffeic acid phenethyl ester against streptomycin ototoxicity. American Journal of Otolaryngology 2013; 34: 16-21.
30. Sud’ina GF, Mirzoeva OK, Pushkareva MA, Korshunova GA, Sumbatyan NV, Varfolomeev SD. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with anti-oxidant properties. FEBS Letters 1993; 329: 21-24.